Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas

Human Pathology

Volumn 38, Issue 4, 2007, Pages 564-569

  Sheehan, Gregory M ^a   Kallakury, Bhaskar V S ^b   Sheehan, Christine E ^a   Fisher, Hugh A G ^a   Kaufman Jr , Ronald P ^a   Ross, Jeffrey S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Claudins; Prognosis; Prostate cancer; Recurrence

Indexed keywords

CLAUDIN 1; CLAUDIN 3; CLAUDIN 4; CLAUDIN 7; PROTEIN ANTIBODY;

ADVANCED CANCER; ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE SECTION; TUMOR RECURRENCE;

ADENOCARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; PROGNOSIS; PROSTATIC NEOPLASMS; TIGHT JUNCTIONS;

EID: 33947148570     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.11.007     Document Type: Article

References (31)

1. Gibson M.C., and Perrimon N. Apicobasal polarization: epithelial form and function. Curr Opin Cell Biol 15 (2003) 747-752
2. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2 (2001) 285-293
3. Kawabe H., Nakanishi H., Asada M., et al. Pilt, a novel peripheral membrane protein at tight junctions in epithelial cells. J Biol Chem 276 (2001) 48350-48355
4. Anderson J.M., and Van Itallie C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269 4 Pt 1 (1995) G467-G475
5. Gonzalez-Mariscal L., Betanzos A., Nava P., and Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 81 (2003) 1-44
6. Gonzalez-Mariscal L., and Nava P. Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation. Adv Drug Deliv Rev 57 (2005) 811-814
7. Mullin J.M. Epithelial barriers, compartmentation, and cancer. Sci STKE 13 (2004) pe2
8. Furuse M., Fujita K., Hiiragi T., et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141 (1998) 1539-1550
9. Morita K., Furuse M., Fujimoto K., and Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 96 (1999) 511-516
10. Morin P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65 (2005) 9603-9606
11. de Oliveira S.S., de Oliveira I.M., De Souza W., et al. Claudins upregulation in human colorectal cancer. FEBS Lett 579 (2005) 6179-6185
12. Resnick M.B., Konkin T., Routhier J., et al. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18 (2005) 511-518
13. Michl P., Buchholz M., Rolke M., et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121 (2001) 678-684
14. Nichols L.S., Ashfaq R., and Iacobuzio-Donahue C.A. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 121 (2004) 226-230
15. Hoevel T., Macek R., Mundigl O., et al. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 191 (2002) 60-68
16. Kominsky S.L., Argani P., Korz D., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22 (2003) 2021-2033
17. Soini Y. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol 35 (2004) 1531-1536
18. Sauer T., Pedersen M.K., Ebeltoft K., et al. Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16 (2005) 193-198
19. Tokes A.M., Kulka J., Paku S., et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7 (2005) R296-R305
20. Agarwal R., D'Souza T., and Morin P.J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65 (2005) 7378-7385
21. Rangel L.B., Agarwal R., D'Souza T., et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9 (2003) 2567-2575
22. Long H., Crean C.D., Lee W.H., et al. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61 (2001) 7878-7881
23. Zheng J.Y., Yu D., Foroohar M., et al. Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol 194 (2003) 187-197
24. Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46 (2005) 551-560
25. Swisshelm K., Macek R., and Kubbies M. Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57 (2005) 919-928
26. Van Itallie C.M., and Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol 68 (2006) 403-429
27. Ebihara C., Kondoh M., Hasuike N., et al. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin. J Pharmacol Exp Ther 316 (2006) 255-260
28. Gleason D.F. Histologic grading of prostate cancer: a perspective. Hum Pathol 23 (1992) 273-279
29. In: Greene F.I., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer staging manual. 6th ed. (2002), Springer, New York 309-316
30. Kallakury B.V., Sheehan C.E., and Ross J.S. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas. Hum Pathol 32 (2001) 849-855
31. D'Souza T., Agarwal R., and Morin P.J. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem 280 (2005) 26233-26240